NasdaqGS - Delayed Quote • USD
Immunic, Inc. (IMUX)
At close: April 23 at 4:00 PM EDT
After hours: April 23 at 7:15 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-70,828.0000
-70,828.0000
-65,144.0000
-83,233.0000
-46,124.0000
Investing Cash Flow
9,462.0000
9,462.0000
-9,741.0000
-67.0000
-146.0000
Financing Cash Flow
1,033.0000
1,033.0000
95,760.0000
42,841.0000
144,431.0000
End Cash Position
46,674.0000
46,674.0000
106,745.0000
86,863.0000
127,452.0000
Capital Expenditure
-334.0000
-334.0000
-112.0000
-67.0000
-146.0000
Issuance of Capital Stock
853.0000
853.0000
95,573.0000
42,749.0000
144,431.0000
Free Cash Flow
-71,162.0000
-71,162.0000
-65,256.0000
-83,300.0000
-46,270.0000
12/31/2020 - 4/17/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACET Adicet Bio, Inc.
2.1000
+5.00%
PASG Passage Bio, Inc.
1.2300
+7.89%
GBIO Generation Bio Co.
3.2600
+16.01%
ALGS Aligos Therapeutics, Inc.
0.8236
+2.82%
VINC Vincerx Pharma, Inc.
0.9500
+9.32%
PLRX Pliant Therapeutics, Inc.
12.52
-0.63%
ATRA Atara Biotherapeutics, Inc.
0.7186
+3.04%
TERN Terns Pharmaceuticals, Inc.
4.6900
-2.70%
BTAI BioXcel Therapeutics, Inc.
2.9700
+4.21%
PSTX Poseida Therapeutics, Inc.
2.1600
+0.23%